Boston, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Weight Loss and Its Cardiovascular Benefits Continue for Five Years in Real-World Clinical Practice

OsamaHamdyMD.jpg

Participants in Joslin's Why WAIT (Weight Achievement and Intensive Management) program lost substantial amounts of weight, and even those who maintained relatively little loss of weight after five years demonstrated reduced risks of cardiovascular...
4-Jan-2017 2:05 PM EST Add to Favorites

Study Suggests Route to Improve Artery Repair

GeorgeKingMDCSO2016.jpg

People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a “stent” surgical tube, the artery is...
4-Jan-2017 1:05 PM EST Add to Favorites

Laurie Goodyear, PhD, Joslin Diabetes Center, Receives One of the First MoTrPAC Grants from NIH

Laurie_Goodyear_PhD_2.jpg

Laurie J. Goodyear, PhD, at Joslin Diabetes Center will be part of the NIH's new MoTrPAC consortium and will help map molecular changes from physical activity.
14-Dec-2016 11:05 AM EST Add to Favorites

Medicare Expands Lifestyle Program to Fight Diabetes Before It Starts

Gabbay-Suit-202x300.jpg

Most people struggle with their weight and are less active than ever before. Taken together, this toxic lifestyle can lead to serious health problems. The truth is that 86 million American adults—more than one out of three—have prediabetes....
11-Nov-2016 2:40 PM EST Add to Favorites

How Important Is the Gut Microbiome? It May Depend on Your Genetics

Dr.CRonaldKahnJDC.jpg

Joslin Diabetes Center investigators are shedding light on how the success of such microbiome treatments may be affected by genetics of the individual or animal being treated.
7-Nov-2016 2:05 PM EST Add to Favorites

Genes Influence Response to Glycemic Control as a Preventive Therapy for Cardiovascular Complications in Type 2 Diabetes

doria57.jpg

Genes play a role in how people with type 2 diabetes at high risk of cardiovascular disease risk respond to intensive glycemic control as an intervention to prevent the disease.
19-Sep-2016 12:05 PM EDT Add to Favorites

Finding New Targets to Treat Vascular Damage

Christian-Rask-Madsen-websize.jpg

There are no established drugs to improve angiogenesis in diabetes. However, researchers at Joslin Diabetes Center now have identified a gene called CITED2 in a molecular pathway that may offer targets for drugs that treat these conditions by...
25-Aug-2016 2:05 PM EDT Add to Favorites

Umbilical Cells Shed Light on How Obesity May Pass From Mother to Child

Elvira-Isganaitis-MD-LabPhotoforPR.jpg

Researchers at Joslin Diabetes Center now have demonstrated that umbilical cells from children of obese or overweight mothers show impaired expression of key genes regulating cell energy and metabolism, compared to similar cells from babies of...
22-Aug-2016 3:05 PM EDT Add to Favorites

Our Experts on Newswise

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

Laffel21.jpg

6-Jan-2015 11:00 AM EST

Back to School with Dr. Lori Laffel from Joslin Diabetes Center

laffel28.jpg

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Joslin Diabetes Center’s Cathy Carver Deciphers the ACA for People with Diabetes

Cathy-Carver.JPG

13-Nov-2013 1:00 PM EST

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

Q&A: Howard Wolpert, M.D., and the Quest for an Artificial Pancreas

Howard_Wolpert_of_Joslin_Diabetes_Center.JPG

Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT

Our YouTube Videos





Chat now!